ATGE Stock Recent News

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Adtalem (ATGE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

CHICAGO--(BUSINESS WIRE)--Adtalem Global Education Inc. (NYSE: ATGE) will release its second quarter fiscal year 2025 results on Thursday, Jan. 30, 2025.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Adtalem Global Education focuses on medical and veterinary education, showing solid profitability and potential growth in a booming healthcare industry. Despite a current ratio below 1.0, ATGE maintains a reasonable price/book ratio and generates significant operating cash flow, indicating financial stability. Risks include reliance on government financial aid, maintaining accreditation, and ensuring student placements in healthcare jobs, which are crucial for sustaining reputation and revenue.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

CHICAGO--(BUSINESS WIRE)--Adtalem Global Education Inc. (NYSE: ATGE) Announces First Quarter Fiscal Year 2025 Conference Call on Oct. 29, 2024.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Adtalem (ATGE) reported earnings 30 days ago. What's next for the stock?